Squawk on the Street

Cramer's Morning Take: Nvidia Earnings 8/29/24

Aug 29, 2024

In this discussion, Jeff Marks, an insightful analyst known for his keen market observations, joins Jim to analyze Nvidia's recent stock slump. They unpack the surprising drop in Nvidia's shares despite a favorable earnings report, highlighting a shift in investor confidence. The pair also delve into Nvidia's financial performance and the promising future of its GPU production, especially with the anticipated launch of new Blackwell products. They emphasize the importance of adapting investment strategies in response to market fluctuations.

03:57

Creator website

Episode guests

Jeff Marks

AI Summary

AI Chapters

Episode notes

Podcast summary created with Snipd AI

Quick takeaways

Nvidia's recent earnings beat expectations but its stock drop reflects investor concerns over delivery issues and market confidence.

The shift towards liquid cooling technology for GPUs indicates a critical evolution in data center infrastructure within the tech industry.

Deep dives

Impact of Trimphia on Psoriatic Arthritis

Trimphia is shown to significantly alleviate joint pain, stiffness, and swelling in adults with active psoriatic arthritis. Clinical observations have indicated that some patients experience reduced fatigue after starting the treatment, enhancing their overall quality of life. The medication is administered through injections six times a year, following two initial starter doses. However, patients must be aware of the potential for serious allergic reactions and increased risk of infections, necessitating pre-treatment screenings for infections and tuberculosis by their healthcare provider.

Intro

2min

Market Analysis: Nvidia's Unexpected Earnings Response

2min

Nvidia's Financial Insights and Market Strategies

3min

Jim and Jeff discuss the share drop in this semiconductor stock. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake

CNBC Investing Club Disclaimer